脑肿瘤手术中的不良事件:发生率、类型及对现行质量指标的影响
该研究回顾性评估了一家德国中心因良性或恶性脑肿瘤住院的成人患者的质量指标与不良事件,共纳入2511例。30天内非计划再入院率为5.7%,主要原因为肿瘤进展;每10例患者中1例发生非计划再手术;感染导致的外科翻修发生率为2.3%。男性患者发生任一监测不良事件的风险更高(OR 1.236,95%CI 1.025-1.490,p=0.027)。
要点
- 30天内非计划再入院率为5.7%,主要原因为肿瘤进展。
- 每10例患者中1例发生非计划再手术,感染导致的外科翻修发生率为2.3%。
- 男性患者发生任一监测不良事件的风险更高(OR 1.236,95%CI 1.025-1.490,p=0.027)。
核心结论
- 大多数结局发生率的预测因素基于术前基础医疗状况,而非外科医生可改变的因素。
- 再入院率和再手术率的差异受决策标准强烈影响,不同医疗提供者之间的国际结局率比较具有挑战性。
- 每个医疗系统必须制定自己的风险调整指标,并需要定期重新评估。
研究设计与样本
- 回顾性评估一家德国中心因良性或恶性脑肿瘤住院的成人患者的质量指标与不良事件。
- 共纳入2511例病例。
- 分析旨在确定不良事件的危险因素以及再入院和再手术的原因。
主要发现
- 30天内非计划再入院至同一医院的率为5.7%,主要原因为肿瘤进展。
- 每10例患者中1例发生非计划再手术。
- 感染导致的外科翻修发生率为2.3%。
- 男性患者发生任一监测不良事件的风险更高(OR 1.236,95%CI 1.025-1.490,p=0.027)。
- 年龄、性别和组织学诊断是发生任一并发症的预测因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of the study was to determine pre-operative factors associated with adverse events occurring within 30 days after neurosurgical tumor treatment in a German center, adjusting for their incidence in order to prospectively compare different centers. METHODS: Adult patients that were hospitalized due to a benign or malignant brain were retrospectively assessed for quality indicators and adverse events. Analyses were performed in order to determine risk factors for adverse events and reasons for readmission and reoperation. RESULTS: A total of 2511 cases were enrolled. The 30 days unplanned readmission rate to the same hospital was 5.7%. The main reason for readmission was tumor progression. Every 10th patient had an unplanned reoperation. The incidence of surgical revisions due to infections was 2.3%. Taking together all monitored adverse events, male patients had a higher risk for any of these complications (OR 1.236, 95%CI 1.025-1.490, p = 0.027). Age, sex, and histological diagnosis were predictors of experiencing any complication. Adjusted by incidence, the increased risk ratios greater than 10.0% were found for male sex, age, metastatic tumor, and hemiplegia for various quality indicators. CONCLUSIONS: We found that most predictors of outcome rates are based on preoperative underlying medical conditions and are not modifiable by the surgeon. Comparing our results to the literature, we conclude that differences in readmission and reoperation rates are strongly influenced by standards in decision making and that comparison of outcome rates between different health-care providers on an international basis is challenging. Each health-care system has to develop own metrics for risk adjustment that require regular reassessment.
引用
- Schipmann S, Brix T, Varghese J, et al. Adverse events in brain tumor surgery: incidence, type, and impact on current quality metrics. Acta Neurochir (Wien). 2019. PMID: 30635727. doi:10.1007/s00701-018-03790-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。